Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Pragya Pandey

HISTORICAL FACTS: Is invitae stock a buy under 5 | History Defined

Genetic testing company Invitae Corporation (NVTA) in San Francisco offers genetic tests in various therapeutic fields, including cardiology, neurology, hereditary cancer, pediatrics, and uncommon disorders.

The stock has slumped 83.1% in price over the past year and 34.2% over the past month to close yesterday's trading session at $5.57. In addition, it is currently trading 84.3% below its 52-week high of $35.51.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.